UNICREDIT BANK/CALL/FRESENIUS/25/0.1/18.12.24 Share Price

Warrant

DE000HC3MAA7

Real-time BOERSE MUENCHEN 01:11:10 05/07/2024 am IST
0.48 EUR +4.35% Intraday chart for UNICREDIT BANK/CALL/FRESENIUS/25/0.1/18.12.24
Current month+11.63%
1 month-14.29%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
04/24/04 0.48 +4.35%
03/24/03 0.46 +2.22%
02/24/02 0.45 -2.17%
01/24/01 0.46 +6.98%
28/24/28 0.43 0.00%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 01:11 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer UniCredit UniCredit
WKN HC3MAA
ISINDE000HC3MAA7
Date issued 30/01/2023
Strike 25
Maturity 18/12/2024 (167 Days)
Parity 10 : 1
Emission price 0.57
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.79
Lowest since issue 0.25
Delta0.79x
Omega 4.672
Premium4.26x
Gearing5.9x
Moneyness 1.145
Difference Strike -3.63
Difference Strike %-14.52%
Spread 0.01
Spread %2.04%
Theoretical value 0.4850
Implied Volatility 31.95 %
Total Loss Probability 27.58 %
Intrinsic value 0.3630
Present value 0.1220
Break even 29.85 €
Theta-0x
Vega0.01x
Rho0.01x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.63 EUR
Average target price
37.26 EUR
Spread / Average Target
+30.13%
Consensus